Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TransMedics (TMDX) Shares Outstanding (Diluted Average) (2020 - 2024)

TransMedics has reported Shares Outstanding (Diluted Average) over the past 5 years, most recently at $35.7 million for Q3 2024.

  • For Q3 2024, Shares Outstanding (Diluted Average) rose 9.88% year-over-year to $35.7 million; the TTM value through Sep 2024 reached $35.7 million, up 9.88%, while the annual FY2023 figure was $32.5 million, 10.02% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q3 2024 was $35.7 million at TransMedics, up from $35.0 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $35.7 million in Q3 2024 and troughed at $21.2 million in Q1 2020.
  • A 5-year average of $29.1 million and a median of $28.0 million in 2022 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 28.96% in 2021 and later rose 1.72% in 2022.
  • Year by year, Shares Outstanding (Diluted Average) stood at $24.7 million in 2020, then increased by 11.8% to $27.6 million in 2021, then rose by 7.02% to $29.6 million in 2022, then grew by 10.02% to $32.5 million in 2023, then grew by 9.74% to $35.7 million in 2024.
  • Business Quant data shows Shares Outstanding (Diluted Average) for TMDX at $35.7 million in Q3 2024, $35.0 million in Q2 2024, and $34.7 million in Q1 2024.